Sanofi Slaps Novo Nordisk Over Safety Needle Patent
Sanofi-Aventis Deutschland GmbH has sued Novo Nordisk Inc. over a safety needle for insulin injection, three days after the diabetes treatment manufacturer hit the pharmaceutical giant with its own declaratory action...To view the full article, register now.
Already a subscriber? Click here to view full article